Becton Dickinson
Becton, Dickinson and Company, widely known as BD, is a premier global medical technology enterprise headquartered in Franklin Lakes, New Jersey. The organization designs, manufactures, and sells advanced medical devices, laboratory instruments, diagnostic equipment, and specialized vascular delivery systems worldwide. Its core business operates across three main segments—BD Medical, BD Life Sciences, and BD Interventional—serving hospitals, clinical laboratories, and research institutions. BD focuses on advancing biological research, expanding diagnostic accuracy, and improving the safety and efficiency of clinical care delivery. To address the expanding healthcare demands of aging global demographics, BD delivers critical technologies for managing chronic diseases, vascular access, and medication management. The company continuously invests in medical engineering, automated diagnostic equipment, and digital health software to reduce hospital-acquired infections and operational errors. Through scientific innovation and extensive distribution networks, BD remains committed to advancing the quality and security of modern global healthcare.
69 of the funds FundTelligence covers report a position in Becton Dickinson.
- Legal name
- Becton Dickinson & Co.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 69
Funds holding Becton Dickinson
- Investerum Equity Value — Investerum · 4.87 % (full portfolio disclosed, June 2026)
- Storebrand Like Muligheter — Storebrand · 4.05 % (full portfolio disclosed, October 2026)
- Fondsfinans Global Helse — Fondsfinans · 2.99 % (full portfolio disclosed, October 2026)
- BGF US Mid-Cap Value Fund — BlackRock · 2.19 % (largest positions only, October 2026)
- Storebrand Global Solutions — Storebrand · 2.1 % (full portfolio disclosed, October 2026)
- Nordea Globale Stabile Aktier - Etisk tilvalg — Nordea Funds · 2.09 % (full portfolio disclosed, July 2026)
- Nordea Stabile Aktier — Nordea Funds · 1.65 % (full portfolio disclosed, July 2026)
- Nordea Globale Stabile Aktier — Nordea Funds · 1.64 % (full portfolio disclosed, July 2026)
Showing the 8 largest of 69 funds holding it.